Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Pioglitazone in PCOS
NCT03117517Phase 1Completed
- Sponsor
- Khyber Medical University
- Start
- Mar 2017
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of pioglitazone in polycystic ovary syndrome (PCOS), sponsored by Khyber Medical University. Primary endpoint: Interleukin-6 at 3 months. Started Mar 2017; status: completed.
02
Drugs
pioglitazone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03117517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03117517.